DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery

Phase 4

Recruiting

Conditions: Elderly
Hip Fracture Surgery
Patient-controlled Analgesia
Dexmedetomidine
Postoperative Delirium

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2021-07-08

Last Posted Date: 2021-11-29

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1440

Registration Number: NCT04955249

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database

Completed

Conditions: Anemia

First Posted Date: 2021-07-02

Last Posted Date: 2022-12-30

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 2519

Registration Number: NCT04948424

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Novel Equation for Estimating Resting Energy Expenditure in Dialysis Patients

Completed

Conditions: Peritoneal Dialysis
Resting Energy Expenditure
Equation

First Posted Date: 2021-07-01

Last Posted Date: 2022-09-29

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 200

Registration Number: NCT04947839

Locations: 🇨🇳
Peking Haidian Hospital, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Epidural Analgesia and Maternal Fever During Labor

Completed

Conditions: Analgesic Effect
Fever
Epidural Analgesia

Interventions: Drug: Epidural analgesia

First Posted Date: 2021-06-25

Last Posted Date: 2025-03-11

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1051

Registration Number: NCT04940091

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Dongguan women and children's hospital, Dongguan, Guangdong, China
🇨🇳
Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China

and more 5 locations

Low-Dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Septic Patients

Not Applicable

Conditions: Dexmedetomidine
Mechanical Ventilation
Delirium
Intensive Care Unit
Adult
Sepsis

Interventions: Drug: Placebo (normal saline)
Drug: Dexmedetomidine

First Posted Date: 2021-05-07

Last Posted Date: 2022-04-20

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 116

Registration Number: NCT04876937

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Follow up of Ticagrelor Treatment Patterns in Chinese Acute Coronary Syndromes Patients

Conditions: Acute Coronary Syndrome

First Posted Date: 2021-04-27

Last Posted Date: 2021-04-27

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 20000

Registration Number: NCT04861363

Locations: 🇨🇳
Division of Cardiology, Peking University First Hospital, Beijing, China

Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients

Phase 4

Completed

Conditions: Postoperative Nausea and Vomiting
High-risk Patients
Benzodiazepine

Interventions: Drug: Placebo
Drug: Remimazolam

First Posted Date: 2021-04-27

Last Posted Date: 2024-01-03

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 552

Registration Number: NCT04861337

Locations: 🇨🇳
Beijing YouAn Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China
🇨🇳
Suzhou Municipal Hospital, Suzhou, Jiangsu, China

and more 7 locations

Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Not Applicable

Conditions: Antithrombotic Therapy
Perioperative Care
Perioperative Outcomes

Interventions: Drug: Routine management of perioperative antithrombotic therapy
Drug: Protocol-based management of perioperative antithrombotic therapy

First Posted Date: 2021-04-21

Last Posted Date: 2021-07-13

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 526

Registration Number: NCT04852406

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

Phase 2

Recruiting

Conditions: HER2-negative Breast Cancer
Neoadjuvant Therapy
Pathological Complete Response
Immunotherapy
Vinorelbine
Cisplatin

Interventions: Drug: Camrelizumab with vinorelbine and cisplatin

First Posted Date: 2021-04-19

Last Posted Date: 2022-10-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 30

Registration Number: NCT04848454

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Community Study of the Risk for Obstructive Sleep Apnea and Respiratory Inflammation in an Adult Chinese Population

Completed

Conditions: Exhaled Breath Condensate
Obstructive Sleep Apnea
Inflammation
Surveys and Questionnaires

First Posted Date: 2021-04-06

Last Posted Date: 2024-10-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1270

Registration Number: NCT04832711

Locations: 🇨🇳
Jing Ma, Pro., Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy